Aging biomarkers such as p16 have been found to be elevated in aged cortices, and p16 is overexpressed in the frontal cortex of Alzheimer’s disease patients [22]. This evidence concerns the gene CDKN2A and early-onset autosomal dominant Alzheimer disease.